Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

NCT03146663 is registered in ClinicalTrials.gov with NuCana plc as lead sponsor.

NCT NCT03146663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Open-Label Study of NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Lead sponsor
NuCana plc
Phase
Phase 2
Overall status
Terminated
Start date
September 28, 2017
Completion date
December 31, 2019
Enrollment
53 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer